Companies will co-develop inactivated vaccine candidate, COVAXIN™, to prevent COVID-19 infection in the US Builds upon the promising safety and...
CELEBRATION, Fla., Dec. 22, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery...
Latest publication confirms BET inhibitors reduce the levels of critical receptors used by SARS-CoV-2 (COVID-19) to gain entry into cells,...
Beyond retinal detachment, lead candidate ONL1204 will also advance into the chronic conditions of glaucoma and dry age-related macular degeneration...
SAN FRANCISCO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced dosing of the first patient in the...
The dHydronator’s SanitiZen® technology has been proven to reduce the microbial load level of cannabis from failing laboratory testing and...
RESEARCH TRIANGLE PARK, N.C., Dec. 22, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that data from part...
Conference Call and Webcast To be Held Monday, December 28th, 2020 4:30 pm Eastern TimeNEW YORK, Dec. 22, 2020 (GLOBE...
-- Study met primary endpoint and all key secondary endpoints with statistically significant and clinically meaningful reductions in weight and...
Single Local Treatment of OncoPLEX Showed Improved Overall Survival and Significantly Less Tumor Recurrence, and Reduced Systemic Toxicity Compared to...
University of Geneva Technology Covers Broad Applications for Cardiometabolic SyndromesCHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding...
OTTAWA, Dec. 22, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE:HEXO) announces that its amended...
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 NEWCASTLE UPON TYNE, UK,...
Press Release Hørsholm, Denmark (22 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that it...
Press release ...
Study results are expected to support the Company's plans to file an IND application with the FDA for a Phase...
IRVINE, Calif.--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and...
RESTON, Va.--(BUSINESS WIRE)--Siemens Government Technologies (SGT), Inc. – the federally-focused U.S. arm of technology powerhouse Siemens – is honored to...
PARIS, FRANCE / ACCESSWIRE / December 21, 2020 / Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing...
The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test...